# OnCo record paper-clarinet-lanreotide-nejm-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-clarinet-lanreotide-nejm-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-clarinet-lanreotide-nejm-2014" ;
  schema:name "CLARINET: lanreotide in metastatic enteropancreatic neuroendocrine tumours"@en ;
  schema:description "The long-acting somatostatin analogue lanreotide roughly halved the risk of progression in non-functioning gut and pancreatic neuroendocrine tumours, extending the use of these drugs from symptom control to slowing tumour growth."@en ;
  schema:url <https://onco.cc/key-papers/paper-clarinet-lanreotide-nejm-2014/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1316158>, <https://pubmed.ncbi.nlm.nih.gov/25014687/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1316158> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Caplin ME, Pavel M, Ćwikła JB, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:trials <https://onco.cc/trials/clarinet/> ;
  onco:journals <https://onco.cc/journals/nejm/> .